The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Multiple primary tumours: challenges and approaches, a review
Open accessAbstract
When in a patient more than one tumour in the same or a different organ is diagnosed, multiple primary tumours may be present. For epidemiological studies, different definitions of multiple primaries are used with the two main definitions coming from the project Surveillance Epidemiology and End Results and the International Association of Cancer Registries and International Agency for Research on Cancer. The differences in the two definitions have to be taken into consideration when reports on multiple primaries are analysed. In this review, the literature on multiple primaries is reviewed and summarised. Overall, the frequency of multiple primaries is reported in the range of 2-17%. Aetiological factors that may predispose patients to multiple primaries can be grouped into host related, lifestyle factors and environmental influences. Some of the most common cancer predisposition syndromes based on a clinical presentation are discussed and the relevant genetic evaluation and testing are characterised. Importantly, from a clinical standpoint, clinical situations when multiple primaries should be suspected and ruled out in a patient are discussed. Furthermore, general principles and possible treatment strategies for patients with synchronous and metachronous multiple primary tumours are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Hayat, M. J., Howlader, N., Reichman, M. E., & Edwards, B. K. (2007) · The Oncologist · doi:10.1634/theoncologist.12-1-20 · Cited by 1,096
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Hereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., Druker, H., Gallinger, B., Naumer, A., Kohlmann, W., Novokmet, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30249-2 · Cited by 546
Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 421
Paluch-Shimon, S., Cardoso, F., Sessa, C., Balmana, J., Cardoso, M. J., Gilbert, F., & Senkus, E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw327 · Cited by 399
Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008
Donin, N., Filson, C., Drakaki, A., Tan, H., Castillo, A., Kwan, L., Litwin, M., & Chamie, K. (2016) · Cancer · doi:10.1002/cncr.30164 · Cited by 343
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Gabai-Kapara, E., Lahad, A., Kaufman, B., Friedman, E., Segev, S., Renbaum, P., Beeri, R., Gal, M., Grinshpun-Cohen, J., Djemal, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415979111 · Cited by 342
Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction
Wood, M. E., Vogel, V., Ng, A., Foxhall, L., Goodwin, P., & Travis, L. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8681 · Cited by 323
Cancer Survival: An Overview of Measures, Uses, and Interpretation
Mariotto, A. B., Noone, A.-M., Howlader, N., Cho, H., Keel, G. E., Garshell, J., Woloshin, S., & Schwartz, L. M. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu024 · Cited by 295
Detection of unexpected additional primary malignancies with PET/CT.
Ishimori, T., Patel, P. V., & Wahl, R. L. (2005) · PubMed · Cited by 280
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Wallis, C. J. D., Mahar, A. L., Choo, R., Herschorn, S., Kodama, R. T., Shah, P. S., Danjoux, C., Narod, S. A., & Nam, R. K. (2016) · BMJ · doi:10.1136/bmj.i851 · Cited by 271
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.
Friedenson, B. (2005) · PubMed Central · Cited by 218
Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Balaguer, F., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt209 · Cited by 165
Multiple tumours in survival estimates
Rosso, S., Angelis, R. D., Ciccolallo, L., Carrani, E., Soerjomataram, I., Grande, E., Zigon, G., & Brenner, H. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.030 · Cited by 153
Epidemiology of Multiple Primary Cancers
Soerjomataram, I., & Coebergh, J. W. W. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_5 · Cited by 126
Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
Win, A. K., Lindor, N. M., Winship, I., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs525 · Cited by 106
Ricceri, F., Fasanelli, F., Giraudo, M. T., Sieri, S., Tumino, R., Mattiello, A., Vagliano, L., Masala, G., Quirós, J. R., Travier, N., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29462 · Cited by 103
Molina‐Montes, E., Perez-Nevot, B., Pollán, M., Sánchez‐Cantalejo, E., Espín, J., & Sánchez, M. (2014) · The Breast · doi:10.1016/j.breast.2014.10.005 · Cited by 99
The effect of multiple primary rules on population-based cancer survival
Weir, H. K., Johnson, C. J., & Thompson, T. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0203-3 · Cited by 94
Hauben, E. I., Arends, J., Vandenbroucke, J. P., van Asperen, C. J., Marck, E. V., & Hogendoorn, P. C. W. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201012 · Cited by 94
Multiple endocrine neoplasia type 1 (MEN1)
Pang, J. T., & Thakker, R. V. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00387-k · Cited by 77
Management of von Hippel-Lindau Disease: An Interdisciplinary Review
Schmid, S., Gillessen, S., Binet, I., Brändle, M., Engeler, D. S., Greiner, J., Hader, C., Heinimann, K., Kloos, P., Krek, W., et al. (2014) · Oncology Research and Treatment · doi:10.1159/000369362 · Cited by 73
Self-citationSuccesses and Challenges of PARP Inhibitors in Cancer Therapy
Ricks, T. K., Chiu, H.-J., Ison, G., Kim, G., McKee, A. E., Kluetz, P. G., & Pazdur, R. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00222 · Cited by 70
Multiple cancers of the head and neck.
Ad, H. C., Danciu, C. E., & Popescu, C. R. (2013) · PubMed · Cited by 63
Induction of Cutaneous Squamous Cell Carcinomas by RAF Inhibitors: Cause for Concern?
Lacouture, M. E., O'Reilly, K. E., Rosen, N. X., & Solit, D. B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2895 · Cited by 63
Analysis of Second Primary Lung Cancers in the SEER Database
Bhaskarla, A. V., Tang, P. C., Mashtare, T. L., Nwogu, C. E., Demmy, T. L., Adjei, A. A., Reid, M. E., & Yendamuri, S. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2009.12.030 · Cited by 51
Bhuller, K. S., Zhang, Y., Li, D., Sehn, L. H., Goddard, K., McBride, M. L., & Rogers, P. C. (2016) · British Journal of Haematology · doi:10.1111/bjh.13903 · Cited by 48
Cancer survivors in Switzerland: a rapidly growing population to care for
Herrmann, C., Cerny, T., Savidan, A., Vounatsou, P., Konzelmann, I., Bouchardy, C., Frick, H., & Ess, S. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-287 · Cited by 36
Self-citationDisease Recurrence and Second Tumors in Long-term Survivors of Lung Cancer
Escuín, J. S. D. C., López, D. P. R., Delgado, I. U., Domínguez, R. G., González, M. A. S., & Valle, M. H. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2016.02.005 · Cited by 18
Cited by
A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease
Borghammer, P., Just, M. K., Horsager, J., Skjærbæk, C., Raunio, A., Kok, E. H., Savola, S., Murayama, S., Saito, Y., Myllykangas, L., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00436-2 · Cited by 127
Metadata
- Authors
- Vogt, A., Schmid, S., Heinimann, K., Frick, H., Herrmann, C., Cerny, T., & Omlin, A.
- Venue
- ESMO Open
- Publisher
- Elsevier BV
- Published
- 2017
- Volume
- 2
- Issue
- 2
- Pages
- e000172
- ISSN
- 2059-7029 (ISSN-L)
- OpenAlex
- W2610723832
- Cited by
- 628
- References
- 36
- FWCI
- 21.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.